Form of Ecstasy may help to combat cancer

John von Radowitz
Thursday 18 August 2011 19:00 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Modified forms of the drug Ecstasy may be effective against leukaemia, lymphoma and myeloma, early research has suggested.

Six years ago scientists found that cancers affecting white blood cells appeared to respond to certain "psychotropic" drugs. These included weight-loss pills, Prozac-type anti-depressants and amphetamine derivatives such as MDMA, commonly known as Ecstasy. Today the same team at the University of Birmingham revealed that specially modified forms of Ecstasy boosted the drug's ability to destroy cancerous cells 100 times.

Further work could lead to MDMA derivatives being used in patient trials. Professor John Gordon, from the university's School of Immunology and Infection, said: "This is an exciting next step towards using a modified form of MDMA to help people suffering from blood cancer. While we would not wish to give people false hope, the results of this research hold the potential for improvements in treatments."

Adapting Ecstasy for use as a cancer drug was problematic at first. Research showed the dose of MDMA needed to treat a tumour would be fatal. To overcome this, the scientists set about isolating the drug's cancer-killing properties.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in